region_id,region_name,location_id,location_name,sex_id,sex,age_group_id,age_group_name,year_id,cause_id,cause_name,measure_name,metric_name,val,upper,lower32,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,491,Cardiovascular diseases,Deaths,Rate,,0.0056500180,0.004730279032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,492,Rheumatic heart disease,Deaths,Rate,0.0000357000,0.0000403000,0.000031200032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,493,Ischemic heart disease,Deaths,Rate,0.0030657310,0.0033419690,0.002797134032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,495,Ischemic stroke,Deaths,Rate,0.0008978430,0.0009765420,0.000818382032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,496,Intracerebral hemorrhage,Deaths,Rate,0.0005633940,0.0006233890,0.000513772032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,497,Subarachnoid hemorrhage,Deaths,Rate,0.0000613000,0.0000685000,0.000055200032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,498,Hypertensive heart disease,Deaths,Rate,0.0002709480,0.0003073350,0.000230363032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,968,Non-rheumatic calcific aortic valve disease,Deaths,Rate,0.0000039800,0.0000044700,0.000003460032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,969,Non-rheumatic degenerative mitral valve disease,Deaths,Rate,0.0000037300,0.0000041800,0.000003260032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,970,Other non-rheumatic valve diseases,Deaths,Rate,0.0000010000,0.0000012400,0.000000792032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,942,Myocarditis,Deaths,Rate,0.0000098000,0.0000123000,0.000007600032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,938,Alcoholic cardiomyopathy,Deaths,Rate,0.0000113000,0.0000143000,0.000008570032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,944,Other cardiomyopathy,Deaths,Rate,0.0001419000,0.0001710630,0.000114758032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,1004,Pulmonary Arterial Hypertension,Deaths,Rate,0.0000049900,0.0000059900,0.000004070032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,500,Atrial fibrillation and flutter,Deaths,Rate,0.0000332000,0.0000365000,0.000029600032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,501,Aortic aneurysm,Deaths,Rate,0.0000234000,0.0000260000,0.000020200032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,502,Lower extremity peripheral arterial disease,Deaths,Rate,0.0000064400,0.0000074300,0.000005630032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,503,Endocarditis,Deaths,Rate,0.0000020100,0.0000022900,0.000001770032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,507,Other cardiovascular and circulatory diseases,Deaths,Rate,0.0000321000,0.0000356000,0.000028800032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,491,Cardiovascular diseases,Deaths,Rate,0.0034268490,0.0038179290,0.003095473032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,492,Rheumatic heart disease,Deaths,Rate,0.0000202000,0.0000246000,0.000014400032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,493,Ischemic heart disease,Deaths,Rate,0.0022865660,0.0025538810,0.002072905032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,495,Ischemic stroke,Deaths,Rate,0.0005570420,0.0006190680,0.000497081032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,496,Intracerebral hemorrhage,Deaths,Rate,0.0001270890,0.0001424450,0.000114198032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,497,Subarachnoid hemorrhage,Deaths,Rate,0.0000248000,0.0000276000,0.000022300032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,498,Hypertensive heart disease,Deaths,Rate,0.0001651550,0.0002064970,0.000130268032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,968,Non-rheumatic calcific aortic valve disease,Deaths,Rate,0.0000033100,0.0000038900,0.000002820032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,969,Non-rheumatic degenerative mitral valve disease,Deaths,Rate,0.0000026700,0.0000031800,0.000002200032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,970,Other non-rheumatic valve diseases,Deaths,Rate,0.0000001810,0.0000002710,0.000000116032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,942,Myocarditis,Deaths,Rate,0.0000008850,0.0000013200,0.000000596032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,938,Alcoholic cardiomyopathy,Deaths,Rate,0.0000177000,0.0000254000,0.000012900032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,944,Other cardiomyopathy,Deaths,Rate,0.0000310000,0.0000388000,0.000024500032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,1004,Pulmonary Arterial Hypertension,Deaths,Rate,0.0000008440,0.0000010100,0.000000689032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,500,Atrial fibrillation and flutter,Deaths,Rate,0.0000287000,0.0000324000,0.000025600032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,501,Aortic aneurysm,Deaths,Rate,0.0000970000,0.0001183090,0.000078800032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,502,Lower extremity peripheral arterial disease,Deaths,Rate,0.0000263000,0.0000315000,0.000022200032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,503,Endocarditis,Deaths,Rate,0.0000010300,0.0000012300,0.000000826032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,507,Other cardiovascular and circulatory diseases,Deaths,Rate,0.0000364000,0.0000437000,0.000030400032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,491,Cardiovascular diseases,Deaths,Rate,0.0062650740,0.0068891870,0.005607110032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,492,Rheumatic heart disease,Deaths,Rate,0.0000166000,0.0000246000,0.000009860032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,493,Ischemic heart disease,Deaths,Rate,0.0043719140,0.0049595630,0.003835413032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,495,Ischemic stroke,Deaths,Rate,0.0005631250,0.0006789010,0.000471793032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,496,Intracerebral hemorrhage,Deaths,Rate,0.0007542000,0.0009157760,0.000611257032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,497,Subarachnoid hemorrhage,Deaths,Rate,0.0000131000,0.0000199000,0.000007640032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,498,Hypertensive heart disease,Deaths,Rate,0.0002859820,0.0004010810,0.000185590032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,968,Non-rheumatic calcific aortic valve disease,Deaths,Rate,0.0000008210,0.0000010900,0.000000580032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,969,Non-rheumatic degenerative mitral valve disease,Deaths,Rate,0.0000004310,0.0000006060,0.000000304032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,970,Other non-rheumatic valve diseases,Deaths,Rate,0.0000000538,0.0000000918,0.000000025232,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,942,Myocarditis,Deaths,Rate,0.0000096100,0.0000196000,0.000005110032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,938,Alcoholic cardiomyopathy,Deaths,Rate,0.0000036400,0.0000119000,0.000000310032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,944,Other cardiomyopathy,Deaths,Rate,0.0001618730,0.0002332270,0.000098000032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,1004,Pulmonary Arterial Hypertension,Deaths,Rate,0.0000073800,0.0000113000,0.000004820032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,500,Atrial fibrillation and flutter,Deaths,Rate,0.0000290000,0.0000352000,0.000022800032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,501,Aortic aneurysm,Deaths,Rate,0.0000170000,0.0000244000,0.000011600032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,502,Lower extremity peripheral arterial disease,Deaths,Rate,0.0000052600,0.0000099300,0.000002360032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,503,Endocarditis,Deaths,Rate,0.0000003410,0.0000005150,0.000000228032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,507,Other cardiovascular and circulatory diseases,Deaths,Rate,0.0000248000,0.0000329000,0.000016600032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,491,Cardiovascular diseases,Deaths,Rate,0.0042482800,0.0047237190,0.003860888032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,492,Rheumatic heart disease,Deaths,Rate,0.0000499000,0.0000573000,0.000042400032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,493,Ischemic heart disease,Deaths,Rate,0.0014749830,0.0016705150,0.001322858032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,495,Ischemic stroke,Deaths,Rate,0.0011703790,0.0012848050,0.001049205032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,496,Intracerebral hemorrhage,Deaths,Rate,0.0006277500,0.0006988240,0.000556277032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,497,Subarachnoid hemorrhage,Deaths,Rate,0.0001006650,0.0001138870,0.000086800032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,498,Hypertensive heart disease,Deaths,Rate,0.0005530040,0.0006223030,0.000478518032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,968,Non-rheumatic calcific aortic valve disease,Deaths,Rate,0.0000139000,0.0000162000,0.000011800032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,969,Non-rheumatic degenerative mitral valve disease,Deaths,Rate,0.0000148000,0.0000169000,0.000012700032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,970,Other non-rheumatic valve diseases,Deaths,Rate,0.0000034900,0.0000048700,0.000002480032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,942,Myocarditis,Deaths,Rate,0.0000073800,0.0000096200,0.000005270032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,938,Alcoholic cardiomyopathy,Deaths,Rate,0.0000042500,0.0000065100,0.000002900032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,944,Other cardiomyopathy,Deaths,Rate,0.0000608000,0.0000738000,0.000050400032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,1004,Pulmonary Arterial Hypertension,Deaths,Rate,0.0000118000,0.0000148000,0.000009480032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,500,Atrial fibrillation and flutter,Deaths,Rate,0.0000634000,0.0000704000,0.000055500032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,501,Aortic aneurysm,Deaths,Rate,0.0000321000,0.0000372000,0.000026900032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,502,Lower extremity peripheral arterial disease,Deaths,Rate,0.0000101000,0.0000116000,0.000008640032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,503,Endocarditis,Deaths,Rate,0.0000031900,0.0000037500,0.000002600032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,507,Other cardiovascular and circulatory diseases,Deaths,Rate,0.0000464000,0.0000536000,0.000038700032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,491,Cardiovascular diseases,Deaths,Rate,0.0047824690,0.0052971460,0.004291750032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,492,Rheumatic heart disease,Deaths,Rate,0.0000198000,0.0000242000,0.000015100032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,493,Ischemic heart disease,Deaths,Rate,0.0024432150,0.0027107610,0.002188245032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,495,Ischemic stroke,Deaths,Rate,0.0010429230,0.0011615000,0.000927042032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,496,Intracerebral hemorrhage,Deaths,Rate,0.0005730560,0.0006493560,0.000500250032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,497,Subarachnoid hemorrhage,Deaths,Rate,0.0000670000,0.0000770000,0.000057600032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,498,Hypertensive heart disease,Deaths,Rate,0.0000962000,0.0001156470,0.000077400032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,968,Non-rheumatic calcific aortic valve disease,Deaths,Rate,0.0000024600,0.0000029600,0.000002020032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,969,Non-rheumatic degenerative mitral valve disease,Deaths,Rate,0.0000028900,0.0000034800,0.000002380032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,970,Other non-rheumatic valve diseases,Deaths,Rate,0.0000007380,0.0000009930,0.000000515032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,942,Myocarditis,Deaths,Rate,0.0000264000,0.0000350000,0.000018300032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,938,Alcoholic cardiomyopathy,Deaths,Rate,0.0000114000,0.0000195000,0.000005940032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,944,Other cardiomyopathy,Deaths,Rate,0.0004043200,0.0004887130,0.000314109032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,1004,Pulmonary Arterial Hypertension,Deaths,Rate,0.0000005120,0.0000006020,0.000000411032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,500,Atrial fibrillation and flutter,Deaths,Rate,0.0000309000,0.0000352000,0.000026500032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,501,Aortic aneurysm,Deaths,Rate,0.0000232000,0.0000283000,0.000018700032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,502,Lower extremity peripheral arterial disease,Deaths,Rate,0.0000024400,0.0000030400,0.000001970032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,503,Endocarditis,Deaths,Rate,0.0000035700,0.0000041900,0.000002850032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,507,Other cardiovascular and circulatory diseases,Deaths,Rate,0.0000314000,0.0000359000,0.000026000032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,491,Cardiovascular diseases,Deaths,Rate,0.0042737090,0.0047823000,0.003810333032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,492,Rheumatic heart disease,Deaths,Rate,0.0000296000,0.0000350000,0.000024600032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,493,Ischemic heart disease,Deaths,Rate,0.0029072760,0.0032427110,0.002584464032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,495,Ischemic stroke,Deaths,Rate,0.0006274170,0.0007070760,0.000564511032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,496,Intracerebral hemorrhage,Deaths,Rate,0.0002913020,0.0003284320,0.000262168032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,497,Subarachnoid hemorrhage,Deaths,Rate,0.0000638000,0.0000749000,0.000057000032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,498,Hypertensive heart disease,Deaths,Rate,0.0001873780,0.0002126960,0.000157393032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,968,Non-rheumatic calcific aortic valve disease,Deaths,Rate,0.0000011600,0.0000013500,0.000000941032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,969,Non-rheumatic degenerative mitral valve disease,Deaths,Rate,0.0000013700,0.0000015900,0.000001100032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,970,Other non-rheumatic valve diseases,Deaths,Rate,0.0000003190,0.0000004480,0.000000215032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,942,Myocarditis,Deaths,Rate,0.0000058500,0.0000076300,0.000004670032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,938,Alcoholic cardiomyopathy,Deaths,Rate,0.0000829000,0.0001013900,0.000069600032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,944,Other cardiomyopathy,Deaths,Rate,0.0000133000,0.0000165000,0.000010800032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,1004,Pulmonary Arterial Hypertension,Deaths,Rate,0.0000005100,0.0000006010,0.000000430032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,500,Atrial fibrillation and flutter,Deaths,Rate,0.0000232000,0.0000261000,0.000020100032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,501,Aortic aneurysm,Deaths,Rate,0.0000083300,0.0000096400,0.000006740032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,502,Lower extremity peripheral arterial disease,Deaths,Rate,0.0000066400,0.0000077900,0.000005490032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,503,Endocarditis,Deaths,Rate,0.0000012500,0.0000014700,0.000001040032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,507,Other cardiovascular and circulatory diseases,Deaths,Rate,0.0000221000,0.0000248000,0.000018900032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,491,Cardiovascular diseases,Deaths,Rate,0.0041988540,0.0047521380,0.003700923032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,492,Rheumatic heart disease,Deaths,Rate,0.0000348000,0.0000418000,0.000028700032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,493,Ischemic heart disease,Deaths,Rate,0.0024460240,0.0027305780,0.002142629032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,495,Ischemic stroke,Deaths,Rate,0.0002508140,0.0003134920,0.000195276032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,496,Intracerebral hemorrhage,Deaths,Rate,0.0009931870,0.0012304360,0.000808714032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,497,Subarachnoid hemorrhage,Deaths,Rate,0.0001269520,0.0001659690,0.000095000032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,498,Hypertensive heart disease,Deaths,Rate,0.0000959000,0.0001284840,0.000059400032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,968,Non-rheumatic calcific aortic valve disease,Deaths,Rate,0.0000030200,0.0000041700,0.000002080032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,969,Non-rheumatic degenerative mitral valve disease,Deaths,Rate,0.0000040700,0.0000056600,0.000003060032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,970,Other non-rheumatic valve diseases,Deaths,Rate,0.0000007430,0.0000013700,0.000000376032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,942,Myocarditis,Deaths,Rate,0.0000088600,0.0000134000,0.000005250032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,938,Alcoholic cardiomyopathy,Deaths,Rate,0.0000401000,0.0000637000,0.000011000032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,944,Other cardiomyopathy,Deaths,Rate,0.0001135860,0.0001521960,0.000083300032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,1004,Pulmonary Arterial Hypertension,Deaths,Rate,0.0000163000,0.0000217000,0.000009070032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,500,Atrial fibrillation and flutter,Deaths,Rate,0.0000219000,0.0000265000,0.000017900032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,501,Aortic aneurysm,Deaths,Rate,0.0000070000,0.0000090400,0.000005440032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,502,Lower extremity peripheral arterial disease,Deaths,Rate,0.0000140000,0.0000221000,0.000009590032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,503,Endocarditis,Deaths,Rate,0.0000021700,0.0000031000,0.000001560032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,507,Other cardiovascular and circulatory diseases,Deaths,Rate,0.0000194000,0.0000260000,0.000014500032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,491,Cardiovascular diseases,Deaths,Rate,0.0062461050,0.0069017640,0.005519571032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,492,Rheumatic heart disease,Deaths,Rate,0.0000220000,0.0000297000,0.000017000032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,493,Ischemic heart disease,Deaths,Rate,0.0037121670,0.0041842970,0.003239640032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,495,Ischemic stroke,Deaths,Rate,0.0011108730,0.0013317680,0.000896664032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,496,Intracerebral hemorrhage,Deaths,Rate,0.0007750200,0.0009656880,0.000642742032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,497,Subarachnoid hemorrhage,Deaths,Rate,0.0000552000,0.0000720000,0.000036200032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,498,Hypertensive heart disease,Deaths,Rate,0.0005127040,0.0007166310,0.000352612032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,968,Non-rheumatic calcific aortic valve disease,Deaths,Rate,0.0000001080,0.0000001640,0.000000068532,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,969,Non-rheumatic degenerative mitral valve disease,Deaths,Rate,0.0000000794,0.0000001430,0.000000045832,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,970,Other non-rheumatic valve diseases,Deaths,Rate,0.0000000796,0.0000001280,0.000000045932,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,942,Myocarditis,Deaths,Rate,0.0000000701,0.0000001130,0.000000038632,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,938,Alcoholic cardiomyopathy,Deaths,Rate,0.0000000079,0.0000000223,0.000000000532,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,944,Other cardiomyopathy,Deaths,Rate,0.0000151000,0.0000198000,0.000011300032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,1004,Pulmonary Arterial Hypertension,Deaths,Rate,0.0000104000,0.0000145000,0.000006930032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,500,Atrial fibrillation and flutter,Deaths,Rate,0.0000186000,0.0000225000,0.000015000032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,501,Aortic aneurysm,Deaths,Rate,0.0000035100,0.0000047600,0.000002620032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,502,Lower extremity peripheral arterial disease,Deaths,Rate,0.0000030300,0.0000050700,0.000001830032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,503,Endocarditis,Deaths,Rate,0.0000002920,0.0000003960,0.000000199032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,507,Other cardiovascular and circulatory diseases,Deaths,Rate,0.0000068700,0.0000086600,0.000005060032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,491,Cardiovascular diseases,Deaths,Rate,0.0053937630,0.0065901600,0.004429990032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,492,Rheumatic heart disease,Deaths,Rate,0.0000290000,0.0000392000,0.000021300032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,493,Ischemic heart disease,Deaths,Rate,0.0033550580,0.0040478990,0.002815683032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,495,Ischemic stroke,Deaths,Rate,0.0008737860,0.0010950160,0.000694281032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,496,Intracerebral hemorrhage,Deaths,Rate,0.0006119250,0.0007904270,0.000465632032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,497,Subarachnoid hemorrhage,Deaths,Rate,0.0000820000,0.0001086380,0.000063400032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,498,Hypertensive heart disease,Deaths,Rate,0.0002045710,0.0002827010,0.000152275032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,968,Non-rheumatic calcific aortic valve disease,Deaths,Rate,0.0000012300,0.0000016100,0.000000957032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,969,Non-rheumatic degenerative mitral valve disease,Deaths,Rate,0.0000013000,0.0000017000,0.000000990032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,970,Other non-rheumatic valve diseases,Deaths,Rate,0.0000002230,0.0000003760,0.000000133032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,942,Myocarditis,Deaths,Rate,0.0000106000,0.0000139000,0.000008010032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,938,Alcoholic cardiomyopathy,Deaths,Rate,0.0000052900,0.0000095300,0.000002950032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,944,Other cardiomyopathy,Deaths,Rate,0.0001400110,0.0001822780,0.000111334032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,1004,Pulmonary Arterial Hypertension,Deaths,Rate,0.0000022900,0.0000030800,0.000001670032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,500,Atrial fibrillation and flutter,Deaths,Rate,0.0000282000,0.0000368000,0.000022700032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,501,Aortic aneurysm,Deaths,Rate,0.0000183000,0.0000258000,0.000014200032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,502,Lower extremity peripheral arterial disease,Deaths,Rate,0.0000033500,0.0000043000,0.000002470032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,503,Endocarditis,Deaths,Rate,0.0000025600,0.0000036500,0.000001770032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,507,Other cardiovascular and circulatory diseases,Deaths,Rate,0.0000240000,0.0000315000,0.000017800032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,491,Cardiovascular diseases,Deaths,Rate,0.0079832100,0.0087216330,0.007298967032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,492,Rheumatic heart disease,Deaths,Rate,0.0000614000,0.0000723000,0.000052200032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,493,Ischemic heart disease,Deaths,Rate,0.0057633110,0.0062833080,0.005250191032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,495,Ischemic stroke,Deaths,Rate,0.0010406280,0.0011459720,0.000946366032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,496,Intracerebral hemorrhage,Deaths,Rate,0.0005941780,0.0006651580,0.000532246032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,497,Subarachnoid hemorrhage,Deaths,Rate,0.0000652000,0.0000757000,0.000055600032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,498,Hypertensive heart disease,Deaths,Rate,0.0003181760,0.0004131730,0.000233811032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,968,Non-rheumatic calcific aortic valve disease,Deaths,Rate,0.0000041800,0.0000048200,0.000003580032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,969,Non-rheumatic degenerative mitral valve disease,Deaths,Rate,0.0000032300,0.0000038000,0.000002730032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,970,Other non-rheumatic valve diseases,Deaths,Rate,0.0000014800,0.0000021900,0.000000975032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,942,Myocarditis,Deaths,Rate,0.0000025600,0.0000033200,0.000002010032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,938,Alcoholic cardiomyopathy,Deaths,Rate,0.0000000450,0.0000000647,0.000000032332,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,944,Other cardiomyopathy,Deaths,Rate,0.0000290000,0.0000334000,0.000025000032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,1004,Pulmonary Arterial Hypertension,Deaths,Rate,0.0000053600,0.0000065000,0.000004450032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,500,Atrial fibrillation and flutter,Deaths,Rate,0.0000267000,0.0000299000,0.000023300032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,501,Aortic aneurysm,Deaths,Rate,0.0000160000,0.0000193000,0.000013200032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,502,Lower extremity peripheral arterial disease,Deaths,Rate,0.0000019900,0.0000023800,0.000001600032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,503,Endocarditis,Deaths,Rate,0.0000017900,0.0000022000,0.000001480032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,507,Other cardiovascular and circulatory diseases,Deaths,Rate,0.0000479000,0.0000562000,0.000041300032,Central Asia,32,Central Asia,1,Male,1,Under 5,1990,491,Cardiovascular diseases,Deaths,Rate,0.0000341000,0.0000386000,0.000030900032,Central Asia,32,Central Asia,1,Male,1,Under 5,2021,491,Cardiovascular diseases,Deaths,Rate,0.0000157000,0.0000195000,0.000012600032,Central Asia,32,Central Asia,2,Female,1,Under 5,1990,491,Cardiovascular diseases,Deaths,Rate,0.0000294000,0.0000325000,0.000026800032,Central Asia,32,Central Asia,2,Female,1,Under 5,2021,491,Cardiovascular diseases,Deaths,Rate,0.0000132000,0.0000162000,0.000010700032,Central Asia,32,Central Asia,1,Male,9,20 to 24,1990,491,Cardiovascular diseases,Deaths,Rate,0.0001124520,0.0001206700,0.000105213032,Central Asia,32,Central Asia,1,Male,9,20 to 24,2021,491,Cardiovascular diseases,Deaths,Rate,0.0000873000,0.0001032280,0.000074800032,Central Asia,32,Central Asia,2,Female,9,20 to 24,1990,491,Cardiovascular diseases,Deaths,Rate,0.0001133580,0.0001196880,0.000107463032,Central Asia,32,Central Asia,2,Female,9,20 to 24,2021,491,Cardiovascular diseases,Deaths,Rate,0.0000639000,0.0000765000,0.000054200032,Central Asia,32,Central Asia,1,Male,10,25 to 29,1990,491,Cardiovascular diseases,Deaths,Rate,0.0002092410,0.0002295520,0.000188537032,Central Asia,32,Central Asia,1,Male,10,25 to 29,2021,491,Cardiovascular diseases,Deaths,Rate,0.0001491250,0.0001620010,0.000136233032,Central Asia,32,Central Asia,2,Female,10,25 to 29,1990,491,Cardiovascular diseases,Deaths,Rate,0.0001570620,0.0001659540,0.000148807032,Central Asia,32,Central Asia,2,Female,10,25 to 29,2021,491,Cardiovascular diseases,Deaths,Rate,0.0000850000,0.0001000500,0.000072400032,Central Asia,32,Central Asia,1,Male,11,30 to 34,1990,491,Cardiovascular diseases,Deaths,Rate,0.0004568000,0.0004835010,0.000428965032,Central Asia,32,Central Asia,1,Male,11,30 to 34,2021,491,Cardiovascular diseases,Deaths,Rate,0.0003069380,0.0003428370,0.000277568032,Central Asia,32,Central Asia,2,Female,11,30 to 34,1990,491,Cardiovascular diseases,Deaths,Rate,0.0002430680,0.0002586440,0.000227021032,Central Asia,32,Central Asia,2,Female,11,30 to 34,2021,491,Cardiovascular diseases,Deaths,Rate,0.0001355350,0.0001629220,0.000115533032,Central Asia,32,Central Asia,1,Male,12,35 to 39,1990,491,Cardiovascular diseases,Deaths,Rate,0.0009140110,0.0009629460,0.000859666032,Central Asia,32,Central Asia,1,Male,12,35 to 39,2021,491,Cardiovascular diseases,Deaths,Rate,0.0006040790,0.0006718530,0.000545138032,Central Asia,32,Central Asia,2,Female,12,35 to 39,1990,491,Cardiovascular diseases,Deaths,Rate,0.0003882850,0.0004069680,0.000362520032,Central Asia,32,Central Asia,2,Female,12,35 to 39,2021,491,Cardiovascular diseases,Deaths,Rate,0.0002420160,0.0002887840,0.000205925032,Central Asia,32,Central Asia,1,Male,13,40 to 44,1990,491,Cardiovascular diseases,Deaths,Rate,0.0020258920,0.0021102140,0.001937957032,Central Asia,32,Central Asia,1,Male,13,40 to 44,2021,491,Cardiovascular diseases,Deaths,Rate,0.0012096900,0.0013687120,0.001058198032,Central Asia,32,Central Asia,2,Female,13,40 to 44,1990,491,Cardiovascular diseases,Deaths,Rate,0.0007546060,0.0007999060,0.000719367032,Central Asia,32,Central Asia,2,Female,13,40 to 44,2021,491,Cardiovascular diseases,Deaths,Rate,0.0004316310,0.0005039440,0.000369695032,Central Asia,32,Central Asia,1,Male,14,45 to 49,1990,491,Cardiovascular diseases,Deaths,Rate,0.0031125270,0.0032164940,0.002988601032,Central Asia,32,Central Asia,1,Male,14,45 to 49,2021,491,Cardiovascular diseases,Deaths,Rate,0.0022379040,0.0025400480,0.001975797032,Central Asia,32,Central Asia,2,Female,14,45 to 49,1990,491,Cardiovascular diseases,Deaths,Rate,0.0012376990,0.0012966280,0.001162085032,Central Asia,32,Central Asia,2,Female,14,45 to 49,2021,491,Cardiovascular diseases,Deaths,Rate,0.0008386680,0.0009820420,0.000720035032,Central Asia,32,Central Asia,1,Male,15,50 to 54,1990,491,Cardiovascular diseases,Deaths,Rate,0.0056597220,0.0058498460,0.005468609032,Central Asia,32,Central Asia,1,Male,15,50 to 54,2021,491,Cardiovascular diseases,Deaths,Rate,0.0039043320,0.0043975530,0.003432594032,Central Asia,32,Central Asia,2,Female,15,50 to 54,1990,491,Cardiovascular diseases,Deaths,Rate,0.0024947730,0.0025998520,0.002368092032,Central Asia,32,Central Asia,2,Female,15,50 to 54,2021,491,Cardiovascular diseases,Deaths,Rate,0.0014936540,0.0017064890,0.001291294032,Central Asia,32,Central Asia,1,Male,16,55 to 59,1990,491,Cardiovascular diseases,Deaths,Rate,0.0086505650,0.0088927450,0.008337506032,Central Asia,32,Central Asia,1,Male,16,55 to 59,2021,491,Cardiovascular diseases,Deaths,Rate,0.0069201350,0.0078101620,0.006160609032,Central Asia,32,Central Asia,2,Female,16,55 to 59,1990,491,Cardiovascular diseases,Deaths,Rate,0.0042691090,0.0044099140,0.004115605032,Central Asia,32,Central Asia,2,Female,16,55 to 59,2021,491,Cardiovascular diseases,Deaths,Rate,0.0029016010,0.0033298120,0.002534131032,Central Asia,32,Central Asia,1,Male,17,60 to 64,1990,491,Cardiovascular diseases,Deaths,Rate,0.0145441440,0.0148650690,0.014104272032,Central Asia,32,Central Asia,1,Male,17,60 to 64,2021,491,Cardiovascular diseases,Deaths,Rate,0.0121282830,0.0134853830,0.010806329032,Central Asia,32,Central Asia,2,Female,17,60 to 64,1990,491,Cardiovascular diseases,Deaths,Rate,0.0078803570,0.0080935890,0.007603541032,Central Asia,32,Central Asia,2,Female,17,60 to 64,2021,491,Cardiovascular diseases,Deaths,Rate,0.0058524730,0.0065991710,0.005190916032,Central Asia,32,Central Asia,1,Male,18,65 to 69,1990,491,Cardiovascular diseases,Deaths,Rate,0.0231473820,0.0237059010,0.022507809032,Central Asia,32,Central Asia,1,Male,18,65 to 69,2021,491,Cardiovascular diseases,Deaths,Rate,0.0208700020,0.0231974450,0.018791305032,Central Asia,32,Central Asia,2,Female,18,65 to 69,1990,491,Cardiovascular diseases,Deaths,Rate,0.0141171800,0.0144746520,0.013652449032,Central Asia,32,Central Asia,2,Female,18,65 to 69,2021,491,Cardiovascular diseases,Deaths,Rate,0.0115059750,0.0128832310,0.010358149032,Central Asia,32,Central Asia,1,Male,19,70 to 74,1990,491,Cardiovascular diseases,Deaths,Rate,0.0357351280,0.0366074300,0.034622260032,Central Asia,32,Central Asia,1,Male,19,70 to 74,2021,491,Cardiovascular diseases,Deaths,Rate,0.0336004170,0.0369442680,0.030435089032,Central Asia,32,Central Asia,2,Female,19,70 to 74,1990,491,Cardiovascular diseases,Deaths,Rate,0.0242719220,0.0249571710,0.023375594032,Central Asia,32,Central Asia,2,Female,19,70 to 74,2021,491,Cardiovascular diseases,Deaths,Rate,0.0206210220,0.0229365800,0.018664685032,Central Asia,32,Central Asia,1,Male,20,75 to 79,1990,491,Cardiovascular diseases,Deaths,Rate,0.0572607200,0.0587432520,0.055135377032,Central Asia,32,Central Asia,1,Male,20,75 to 79,2021,491,Cardiovascular diseases,Deaths,Rate,0.0621059330,0.0673176210,0.056875736032,Central Asia,32,Central Asia,2,Female,20,75 to 79,1990,491,Cardiovascular diseases,Deaths,Rate,0.0434017810,0.0445264990,0.041231379032,Central Asia,32,Central Asia,2,Female,20,75 to 79,2021,491,Cardiovascular diseases,Deaths,Rate,0.0413107440,0.0458283590,0.037396235032,Central Asia,32,Central Asia,1,Male,30,80 to 84,1990,491,Cardiovascular diseases,Deaths,Rate,0.0871794450,0.0896916290,0.082367257032,Central Asia,32,Central Asia,1,Male,30,80 to 84,2021,491,Cardiovascular diseases,Deaths,Rate,0.0964801990,0.1032123700,0.089996104032,Central Asia,32,Central Asia,2,Female,30,80 to 84,1990,491,Cardiovascular diseases,Deaths,Rate,0.0718838690,0.0747522250,0.066134131032,Central Asia,32,Central Asia,2,Female,30,80 to 84,2021,491,Cardiovascular diseases,Deaths,Rate,0.0835506530,0.0905175800,0.075793769032,Central Asia,32,Central Asia,1,Male,31,85 to 89,1990,491,Cardiovascular diseases,Deaths,Rate,0.1252306900,0.1302089550,0.115072776032,Central Asia,32,Central Asia,1,Male,31,85 to 89,2021,491,Cardiovascular diseases,Deaths,Rate,0.1457704260,0.1547405660,0.134394510032,Central Asia,32,Central Asia,2,Female,31,85 to 89,1990,491,Cardiovascular diseases,Deaths,Rate,0.1067025740,0.1127608150,0.094321918032,Central Asia,32,Central Asia,2,Female,31,85 to 89,2021,491,Cardiovascular diseases,Deaths,Rate,0.1281101550,0.1395821300,0.115749975032,Central Asia,32,Central Asia,1,Male,32,90 to 94,1990,491,Cardiovascular diseases,Deaths,Rate,0.1649138230,0.1739370190,0.144705260032,Central Asia,32,Central Asia,1,Male,32,90 to 94,2021,491,Cardiovascular diseases,Deaths,Rate,0.1905189980,0.2020797440,0.171499233032,Central Asia,32,Central Asia,2,Female,32,90 to 94,1990,491,Cardiovascular diseases,Deaths,Rate,0.1448522770,0.1566930500,0.121448266032,Central Asia,32,Central Asia,2,Female,32,90 to 94,2021,491,Cardiovascular diseases,Deaths,Rate,0.1748727930,0.1899234420,0.153838810032,Central Asia,32,Central Asia,1,Male,188,5 to 19,1990,491,Cardiovascular diseases,Deaths,Rate,0.0000268000,0.0000287000,0.000024900032,Central Asia,32,Central Asia,1,Male,188,5 to 19,2021,491,Cardiovascular diseases,Deaths,Rate,0.0000180000,0.0000203000,0.000015900032,Central Asia,32,Central Asia,2,Female,188,5 to 19,1990,491,Cardiovascular diseases,Deaths,Rate,0.0000256000,0.0000274000,0.000024200032,Central Asia,32,Central Asia,2,Female,188,5 to 19,2021,491,Cardiovascular diseases,Deaths,Rate,0.0000144000,0.0000161000,0.000012800032,Central Asia,32,Central Asia,1,Male,235,95 plus,1990,491,Cardiovascular diseases,Deaths,Rate,0.2171720200,0.2333218310,0.179771062032,Central Asia,32,Central Asia,1,Male,235,95 plus,2021,491,Cardiovascular diseases,Deaths,Rate,0.2553729400,0.2727911330,0.220659081032,Central Asia,32,Central Asia,2,Female,235,95 plus,1990,491,Cardiovascular diseases,Deaths,Rate,0.2021127870,0.2220531500,0.159554075032,Central Asia,32,Central Asia,2,Female,235,95 plus,2021,491,Cardiovascular diseases,Deaths,Rate,0.2501932720,0.2735934410,0.209793794032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,492,Rheumatic heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0014423490,0.0016858450,0.001261618032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,493,Ischemic heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0512837240,0.0561146600,0.046843443032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,495,Ischemic stroke,DALYs (Disability-Adjusted Life Years),Rate,0.0148320440,0.0161386060,0.013683716032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,496,Intracerebral hemorrhage,DALYs (Disability-Adjusted Life Years),Rate,0.0112959340,0.0125947380,0.010224229032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,497,Subarachnoid hemorrhage,DALYs (Disability-Adjusted Life Years),Rate,0.0015029020,0.0017122000,0.001349773032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,498,Hypertensive heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0042128160,0.0048254370,0.003600581032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,968,Non-rheumatic calcific aortic valve disease,DALYs (Disability-Adjusted Life Years),Rate,0.0000856000,0.0001026600,0.000072800032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,969,Non-rheumatic degenerative mitral valve disease,DALYs (Disability-Adjusted Life Years),Rate,0.0001396740,0.0001907070,0.000107907032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,970,Other non-rheumatic valve diseases,DALYs (Disability-Adjusted Life Years),Rate,0.0000214000,0.0000258000,0.000017300032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,942,Myocarditis,DALYs (Disability-Adjusted Life Years),Rate,0.0002943640,0.0003767840,0.000225056032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,938,Alcoholic cardiomyopathy,DALYs (Disability-Adjusted Life Years),Rate,0.0003727560,0.0004734330,0.000280317032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,944,Other cardiomyopathy,DALYs (Disability-Adjusted Life Years),Rate,0.0037398240,0.0045358000,0.002984397032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,1004,Pulmonary Arterial Hypertension,DALYs (Disability-Adjusted Life Years),Rate,0.0001347050,0.0001622640,0.000109154032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,500,Atrial fibrillation and flutter,DALYs (Disability-Adjusted Life Years),Rate,0.0008103990,0.0010041500,0.000659512032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,501,Aortic aneurysm,DALYs (Disability-Adjusted Life Years),Rate,0.0004562300,0.0005131280,0.000392121032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,502,Lower extremity peripheral arterial disease,DALYs (Disability-Adjusted Life Years),Rate,0.0001370910,0.0001880870,0.000104918032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,503,Endocarditis,DALYs (Disability-Adjusted Life Years),Rate,0.0000678000,0.0000785000,0.000059200032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,507,Other cardiovascular and circulatory diseases,DALYs (Disability-Adjusted Life Years),Rate,0.0009889450,0.0011184440,0.000876329032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,492,Rheumatic heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0010518890,0.0013429660,0.000791012032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,493,Ischemic heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0375849410,0.0421440930,0.033714919032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,495,Ischemic stroke,DALYs (Disability-Adjusted Life Years),Rate,0.0095126850,0.0104242790,0.008607301032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,496,Intracerebral hemorrhage,DALYs (Disability-Adjusted Life Years),Rate,0.0027947410,0.0031332470,0.002504426032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,497,Subarachnoid hemorrhage,DALYs (Disability-Adjusted Life Years),Rate,0.0007100160,0.0007952860,0.000632136032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,498,Hypertensive heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0024340250,0.0031465150,0.001894734032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,968,Non-rheumatic calcific aortic valve disease,DALYs (Disability-Adjusted Life Years),Rate,0.0000807000,0.0000969000,0.000065000032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,969,Non-rheumatic degenerative mitral valve disease,DALYs (Disability-Adjusted Life Years),Rate,0.0000998000,0.0001337900,0.000076900032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,970,Other non-rheumatic valve diseases,DALYs (Disability-Adjusted Life Years),Rate,0.0000038900,0.0000056700,0.000002590032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,942,Myocarditis,DALYs (Disability-Adjusted Life Years),Rate,0.0000259000,0.0000390000,0.000017800032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,938,Alcoholic cardiomyopathy,DALYs (Disability-Adjusted Life Years),Rate,0.0005110310,0.0007413700,0.000370358032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,944,Other cardiomyopathy,DALYs (Disability-Adjusted Life Years),Rate,0.0007720350,0.0009677100,0.000615511032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,1004,Pulmonary Arterial Hypertension,DALYs (Disability-Adjusted Life Years),Rate,0.0000220000,0.0000255000,0.000018200032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,500,Atrial fibrillation and flutter,DALYs (Disability-Adjusted Life Years),Rate,0.0007655650,0.0009319570,0.000603514032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,501,Aortic aneurysm,DALYs (Disability-Adjusted Life Years),Rate,0.0019075740,0.0023745130,0.001524907032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,502,Lower extremity peripheral arterial disease,DALYs (Disability-Adjusted Life Years),Rate,0.0004282370,0.0005257530,0.000341853032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,503,Endocarditis,DALYs (Disability-Adjusted Life Years),Rate,0.0000321000,0.0000375000,0.000026300032,Central Asia,33,Armenia,3,Both,27,Age-standardized,2021,507,Other cardiovascular and circulatory diseases,DALYs (Disability-Adjusted Life Years),Rate,0.0012129110,0.0014371270,0.000982183032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,492,Rheumatic heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0009744110,0.0012678000,0.000760231032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,493,Ischemic heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0648515660,0.0736076660,0.056569592032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,495,Ischemic stroke,DALYs (Disability-Adjusted Life Years),Rate,0.0089952340,0.0106919490,0.007535064032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,496,Intracerebral hemorrhage,DALYs (Disability-Adjusted Life Years),Rate,0.0126710700,0.0154021850,0.010148429032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,497,Subarachnoid hemorrhage,DALYs (Disability-Adjusted Life Years),Rate,0.0004092970,0.0005908710,0.000294392032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,498,Hypertensive heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0043774940,0.0061075450,0.003019346032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,968,Non-rheumatic calcific aortic valve disease,DALYs (Disability-Adjusted Life Years),Rate,0.0000342000,0.0000500000,0.000024500032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,969,Non-rheumatic degenerative mitral valve disease,DALYs (Disability-Adjusted Life Years),Rate,0.0000629000,0.0001001940,0.000039200032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,970,Other non-rheumatic valve diseases,DALYs (Disability-Adjusted Life Years),Rate,0.0000012300,0.0000021700,0.000000656032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,942,Myocarditis,DALYs (Disability-Adjusted Life Years),Rate,0.0003130240,0.0006502710,0.000152119032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,938,Alcoholic cardiomyopathy,DALYs (Disability-Adjusted Life Years),Rate,0.0001161150,0.0004081740,0.000011900032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,944,Other cardiomyopathy,DALYs (Disability-Adjusted Life Years),Rate,0.0042995400,0.0063529500,0.002550526032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,1004,Pulmonary Arterial Hypertension,DALYs (Disability-Adjusted Life Years),Rate,0.0001963510,0.0003320450,0.000123003032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,500,Atrial fibrillation and flutter,DALYs (Disability-Adjusted Life Years),Rate,0.0007539320,0.0009359570,0.000573191032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,501,Aortic aneurysm,DALYs (Disability-Adjusted Life Years),Rate,0.0003526170,0.0005612140,0.000212639032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,502,Lower extremity peripheral arterial disease,DALYs (Disability-Adjusted Life Years),Rate,0.0001261230,0.0002365530,0.000069000032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,503,Endocarditis,DALYs (Disability-Adjusted Life Years),Rate,0.0000120000,0.0000187000,0.000008160032,Central Asia,34,Azerbaijan,3,Both,27,Age-standardized,2021,507,Other cardiovascular and circulatory diseases,DALYs (Disability-Adjusted Life Years),Rate,0.0007452190,0.0009451030,0.000575635032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,492,Rheumatic heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0017558470,0.0020572790,0.001474274032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,493,Ischemic heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0272469910,0.0312262670,0.024010490032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,495,Ischemic stroke,DALYs (Disability-Adjusted Life Years),Rate,0.0175731210,0.0192626680,0.015494303032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,496,Intracerebral hemorrhage,DALYs (Disability-Adjusted Life Years),Rate,0.0121143070,0.0136502300,0.010600290032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,497,Subarachnoid hemorrhage,DALYs (Disability-Adjusted Life Years),Rate,0.0025494460,0.0029543600,0.002137430032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,498,Hypertensive heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0081496410,0.0092282320,0.007000943032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,968,Non-rheumatic calcific aortic valve disease,DALYs (Disability-Adjusted Life Years),Rate,0.0002723620,0.0003236330,0.000230833032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,969,Non-rheumatic degenerative mitral valve disease,DALYs (Disability-Adjusted Life Years),Rate,0.0004427010,0.0005464030,0.000371808032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,970,Other non-rheumatic valve diseases,DALYs (Disability-Adjusted Life Years),Rate,0.0000769000,0.0001118800,0.000053300032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,942,Myocarditis,DALYs (Disability-Adjusted Life Years),Rate,0.0002169180,0.0002864960,0.000153310032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,938,Alcoholic cardiomyopathy,DALYs (Disability-Adjusted Life Years),Rate,0.0001464360,0.0002278470,0.000099200032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,944,Other cardiomyopathy,DALYs (Disability-Adjusted Life Years),Rate,0.0015850120,0.0019815660,0.001299739032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,1004,Pulmonary Arterial Hypertension,DALYs (Disability-Adjusted Life Years),Rate,0.0002940180,0.0003734920,0.000238590032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,500,Atrial fibrillation and flutter,DALYs (Disability-Adjusted Life Years),Rate,0.0012854690,0.0015193500,0.001060520032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,501,Aortic aneurysm,DALYs (Disability-Adjusted Life Years),Rate,0.0007284130,0.0008537680,0.000598898032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,502,Lower extremity peripheral arterial disease,DALYs (Disability-Adjusted Life Years),Rate,0.0002207660,0.0002761980,0.000175957032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,503,Endocarditis,DALYs (Disability-Adjusted Life Years),Rate,0.0001013730,0.0001190730,0.000083000032,Central Asia,35,Georgia,3,Both,27,Age-standardized,2021,507,Other cardiovascular and circulatory diseases,DALYs (Disability-Adjusted Life Years),Rate,0.0014724160,0.0017262380,0.001282206032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,492,Rheumatic heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0005902160,0.0007124770,0.000455211032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,493,Ischemic heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0383058120,0.0428933030,0.034045133032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,495,Ischemic stroke,DALYs (Disability-Adjusted Life Years),Rate,0.0168249810,0.0188515690,0.015052747032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,496,Intracerebral hemorrhage,DALYs (Disability-Adjusted Life Years),Rate,0.0115502520,0.0133286580,0.009869171032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,497,Subarachnoid hemorrhage,DALYs (Disability-Adjusted Life Years),Rate,0.0016998970,0.0019521100,0.001444809032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,498,Hypertensive heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0016961130,0.0020519830,0.001362891032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,968,Non-rheumatic calcific aortic valve disease,DALYs (Disability-Adjusted Life Years),Rate,0.0000665000,0.0000831000,0.000053000032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,969,Non-rheumatic degenerative mitral valve disease,DALYs (Disability-Adjusted Life Years),Rate,0.0001170520,0.0001578550,0.000091600032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,970,Other non-rheumatic valve diseases,DALYs (Disability-Adjusted Life Years),Rate,0.0000172000,0.0000226000,0.000012200032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,942,Myocarditis,DALYs (Disability-Adjusted Life Years),Rate,0.0008331910,0.0011245710,0.000578158032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,938,Alcoholic cardiomyopathy,DALYs (Disability-Adjusted Life Years),Rate,0.0004160320,0.0006992490,0.000218516032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,944,Other cardiomyopathy,DALYs (Disability-Adjusted Life Years),Rate,0.0111823260,0.0136455940,0.008548509032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,1004,Pulmonary Arterial Hypertension,DALYs (Disability-Adjusted Life Years),Rate,0.0000154000,0.0000183000,0.000012700032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,500,Atrial fibrillation and flutter,DALYs (Disability-Adjusted Life Years),Rate,0.0008280040,0.0010420390,0.000660115032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,501,Aortic aneurysm,DALYs (Disability-Adjusted Life Years),Rate,0.0005310620,0.0006530800,0.000432111032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,502,Lower extremity peripheral arterial disease,DALYs (Disability-Adjusted Life Years),Rate,0.0000892000,0.0001361500,0.000061000032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,503,Endocarditis,DALYs (Disability-Adjusted Life Years),Rate,0.0001222590,0.0001481260,0.000094200032,Central Asia,36,Kazakhstan,3,Both,27,Age-standardized,2021,507,Other cardiovascular and circulatory diseases,DALYs (Disability-Adjusted Life Years),Rate,0.0010004040,0.0011598960,0.000830642032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,492,Rheumatic heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0014024830,0.0016859140,0.001173682032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,493,Ischemic heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0470460050,0.0528430860,0.042589234032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,495,Ischemic stroke,DALYs (Disability-Adjusted Life Years),Rate,0.0127350890,0.0142693110,0.011622915032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,496,Intracerebral hemorrhage,DALYs (Disability-Adjusted Life Years),Rate,0.0072776550,0.0083344550,0.006430669032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,497,Subarachnoid hemorrhage,DALYs (Disability-Adjusted Life Years),Rate,0.0018363010,0.0021645070,0.001598031032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,498,Hypertensive heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0034249100,0.0038785500,0.002863857032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,968,Non-rheumatic calcific aortic valve disease,DALYs (Disability-Adjusted Life Years),Rate,0.0000397000,0.0000498000,0.000031000032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,969,Non-rheumatic degenerative mitral valve disease,DALYs (Disability-Adjusted Life Years),Rate,0.0000887000,0.0001331480,0.000064000032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,970,Other non-rheumatic valve diseases,DALYs (Disability-Adjusted Life Years),Rate,0.0000086200,0.0000118000,0.000005870032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,942,Myocarditis,DALYs (Disability-Adjusted Life Years),Rate,0.0001713870,0.0002060960,0.000140664032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,938,Alcoholic cardiomyopathy,DALYs (Disability-Adjusted Life Years),Rate,0.0028065070,0.0034047100,0.002341532032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,944,Other cardiomyopathy,DALYs (Disability-Adjusted Life Years),Rate,0.0003291850,0.0004056710,0.000277334032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,1004,Pulmonary Arterial Hypertension,DALYs (Disability-Adjusted Life Years),Rate,0.0000170000,0.0000194000,0.000014500032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,500,Atrial fibrillation and flutter,DALYs (Disability-Adjusted Life Years),Rate,0.0006809990,0.0008693090,0.000552263032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,501,Aortic aneurysm,DALYs (Disability-Adjusted Life Years),Rate,0.0001924880,0.0002244290,0.000155062032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,502,Lower extremity peripheral arterial disease,DALYs (Disability-Adjusted Life Years),Rate,0.0001552670,0.0001952030,0.000120973032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,503,Endocarditis,DALYs (Disability-Adjusted Life Years),Rate,0.0000471000,0.0000550000,0.000040100032,Central Asia,37,Kyrgyzstan,3,Both,27,Age-standardized,2021,507,Other cardiovascular and circulatory diseases,DALYs (Disability-Adjusted Life Years),Rate,0.0008177310,0.0009472780,0.000696228032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,492,Rheumatic heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0015355350,0.0018207590,0.001222725032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,493,Ischemic heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0371200680,0.0422163880,0.031724824032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,495,Ischemic stroke,DALYs (Disability-Adjusted Life Years),Rate,0.0052043720,0.0063291590,0.004315037032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,496,Intracerebral hemorrhage,DALYs (Disability-Adjusted Life Years),Rate,0.0203435860,0.0253591940,0.016622308032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,497,Subarachnoid hemorrhage,DALYs (Disability-Adjusted Life Years),Rate,0.0029896220,0.0038756330,0.002271211032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,498,Hypertensive heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0015793670,0.0021245720,0.000988228032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,968,Non-rheumatic calcific aortic valve disease,DALYs (Disability-Adjusted Life Years),Rate,0.0000749000,0.0001019100,0.000054400032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,969,Non-rheumatic degenerative mitral valve disease,DALYs (Disability-Adjusted Life Years),Rate,0.0001818390,0.0002447190,0.000132512032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,970,Other non-rheumatic valve diseases,DALYs (Disability-Adjusted Life Years),Rate,0.0000188000,0.0000345000,0.000009510032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,942,Myocarditis,DALYs (Disability-Adjusted Life Years),Rate,0.0002498110,0.0003826640,0.000144394032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,938,Alcoholic cardiomyopathy,DALYs (Disability-Adjusted Life Years),Rate,0.0013707620,0.0021772510,0.000398411032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,944,Other cardiomyopathy,DALYs (Disability-Adjusted Life Years),Rate,0.0027871370,0.0037841810,0.002021801032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,1004,Pulmonary Arterial Hypertension,DALYs (Disability-Adjusted Life Years),Rate,0.0004153830,0.0005428000,0.000254201032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,500,Atrial fibrillation and flutter,DALYs (Disability-Adjusted Life Years),Rate,0.0006821090,0.0008818220,0.000520140032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,501,Aortic aneurysm,DALYs (Disability-Adjusted Life Years),Rate,0.0001500460,0.0001946520,0.000111262032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,502,Lower extremity peripheral arterial disease,DALYs (Disability-Adjusted Life Years),Rate,0.0002333650,0.0003234360,0.000163571032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,503,Endocarditis,DALYs (Disability-Adjusted Life Years),Rate,0.0000755000,0.0001097470,0.000053900032,Central Asia,38,Mongolia,3,Both,27,Age-standardized,2021,507,Other cardiovascular and circulatory diseases,DALYs (Disability-Adjusted Life Years),Rate,0.0006898120,0.0008911610,0.000540917032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,492,Rheumatic heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0011763290,0.0014727010,0.000915151032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,493,Ischemic heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0572233680,0.0651312290,0.050651412032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,495,Ischemic stroke,DALYs (Disability-Adjusted Life Years),Rate,0.0174289270,0.0207844050,0.014292562032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,496,Intracerebral hemorrhage,DALYs (Disability-Adjusted Life Years),Rate,0.0144039970,0.0180242700,0.011829927032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,497,Subarachnoid hemorrhage,DALYs (Disability-Adjusted Life Years),Rate,0.0012881190,0.0016362770,0.000935959032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,498,Hypertensive heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0077190270,0.0105999030,0.005273586032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,968,Non-rheumatic calcific aortic valve disease,DALYs (Disability-Adjusted Life Years),Rate,0.0000138000,0.0000220000,0.000007880032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,969,Non-rheumatic degenerative mitral valve disease,DALYs (Disability-Adjusted Life Years),Rate,0.0000519000,0.0000914000,0.000031100032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,970,Other non-rheumatic valve diseases,DALYs (Disability-Adjusted Life Years),Rate,0.0000018000,0.0000027300,0.000001080032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,942,Myocarditis,DALYs (Disability-Adjusted Life Years),Rate,0.0000043700,0.0000059400,0.000003050032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,938,Alcoholic cardiomyopathy,DALYs (Disability-Adjusted Life Years),Rate,0.0000002680,0.0000007280,0.000000032332,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,944,Other cardiomyopathy,DALYs (Disability-Adjusted Life Years),Rate,0.0004243810,0.0005633250,0.000311616032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,1004,Pulmonary Arterial Hypertension,DALYs (Disability-Adjusted Life Years),Rate,0.0002874680,0.0003832140,0.000186195032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,500,Atrial fibrillation and flutter,DALYs (Disability-Adjusted Life Years),Rate,0.0006019190,0.0007636460,0.000460113032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,501,Aortic aneurysm,DALYs (Disability-Adjusted Life Years),Rate,0.0000693000,0.0000949000,0.000050700032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,502,Lower extremity peripheral arterial disease,DALYs (Disability-Adjusted Life Years),Rate,0.0000874000,0.0001429140,0.000055400032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,503,Endocarditis,DALYs (Disability-Adjusted Life Years),Rate,0.0000133000,0.0000187000,0.000008990032,Central Asia,39,Tajikistan,3,Both,27,Age-standardized,2021,507,Other cardiovascular and circulatory diseases,DALYs (Disability-Adjusted Life Years),Rate,0.0002546760,0.0003146230,0.000196261032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,492,Rheumatic heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0015338380,0.0020434860,0.001260283032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,493,Ischemic heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0600968990,0.0731057290,0.049462302032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,495,Ischemic stroke,DALYs (Disability-Adjusted Life Years),Rate,0.0180823970,0.0222676200,0.014584330032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,496,Intracerebral hemorrhage,DALYs (Disability-Adjusted Life Years),Rate,0.0155932330,0.0197491030,0.012118289032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,497,Subarachnoid hemorrhage,DALYs (Disability-Adjusted Life Years),Rate,0.0025124150,0.0032777260,0.001971695032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,498,Hypertensive heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0039115680,0.0054040680,0.002901427032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,968,Non-rheumatic calcific aortic valve disease,DALYs (Disability-Adjusted Life Years),Rate,0.0000472000,0.0000616000,0.000035200032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,969,Non-rheumatic degenerative mitral valve disease,DALYs (Disability-Adjusted Life Years),Rate,0.0000973000,0.0001466740,0.000067200032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,970,Other non-rheumatic valve diseases,DALYs (Disability-Adjusted Life Years),Rate,0.0000072800,0.0000117000,0.000004580032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,942,Myocarditis,DALYs (Disability-Adjusted Life Years),Rate,0.0003967410,0.0005149350,0.000308830032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,938,Alcoholic cardiomyopathy,DALYs (Disability-Adjusted Life Years),Rate,0.0001895440,0.0003385590,0.000106245032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,944,Other cardiomyopathy,DALYs (Disability-Adjusted Life Years),Rate,0.0046323360,0.0060025470,0.003606219032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,1004,Pulmonary Arterial Hypertension,DALYs (Disability-Adjusted Life Years),Rate,0.0000761000,0.0000990000,0.000056000032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,500,Atrial fibrillation and flutter,DALYs (Disability-Adjusted Life Years),Rate,0.0008195320,0.0010115770,0.000642675032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,501,Aortic aneurysm,DALYs (Disability-Adjusted Life Years),Rate,0.0004415450,0.0006309510,0.000338276032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,502,Lower extremity peripheral arterial disease,DALYs (Disability-Adjusted Life Years),Rate,0.0001068670,0.0001515820,0.000075300032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,503,Endocarditis,DALYs (Disability-Adjusted Life Years),Rate,0.0001025150,0.0001523860,0.000070700032,Central Asia,40,Turkmenistan,3,Both,27,Age-standardized,2021,507,Other cardiovascular and circulatory diseases,DALYs (Disability-Adjusted Life Years),Rate,0.0008874130,0.0011249330,0.000689436032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,492,Rheumatic heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0021981890,0.0025980230,0.001861429032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,493,Ischemic heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0851618470,0.0944515120,0.076711389032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,495,Ischemic stroke,DALYs (Disability-Adjusted Life Years),Rate,0.0169167900,0.0189649410,0.015235527032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,496,Intracerebral hemorrhage,DALYs (Disability-Adjusted Life Years),Rate,0.0112446520,0.0127580940,0.009915089032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,497,Subarachnoid hemorrhage,DALYs (Disability-Adjusted Life Years),Rate,0.0014358420,0.0016579620,0.001241071032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,498,Hypertensive heart disease,DALYs (Disability-Adjusted Life Years),Rate,0.0051247420,0.0067594380,0.004003002032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,968,Non-rheumatic calcific aortic valve disease,DALYs (Disability-Adjusted Life Years),Rate,0.0000947000,0.0001106600,0.000079200032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,969,Non-rheumatic degenerative mitral valve disease,DALYs (Disability-Adjusted Life Years),Rate,0.0001399540,0.0001969330,0.000101236032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,970,Other non-rheumatic valve diseases,DALYs (Disability-Adjusted Life Years),Rate,0.0000324000,0.0000453000,0.000022400032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,942,Myocarditis,DALYs (Disability-Adjusted Life Years),Rate,0.0000711000,0.0000891000,0.000057500032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,938,Alcoholic cardiomyopathy,DALYs (Disability-Adjusted Life Years),Rate,0.0000013900,0.0000019400,0.000001030032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,944,Other cardiomyopathy,DALYs (Disability-Adjusted Life Years),Rate,0.0007252140,0.0008363130,0.000613251032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,1004,Pulmonary Arterial Hypertension,DALYs (Disability-Adjusted Life Years),Rate,0.0001363080,0.0001645680,0.000114616032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,500,Atrial fibrillation and flutter,DALYs (Disability-Adjusted Life Years),Rate,0.0006988900,0.0008632270,0.000565808032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,501,Aortic aneurysm,DALYs (Disability-Adjusted Life Years),Rate,0.0002805660,0.0003398800,0.000231718032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,502,Lower extremity peripheral arterial disease,DALYs (Disability-Adjusted Life Years),Rate,0.0000714000,0.0001104350,0.000048500032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,503,Endocarditis,DALYs (Disability-Adjusted Life Years),Rate,0.0000624000,0.0000752000,0.000051900032,Central Asia,41,Uzbekistan,3,Both,27,Age-standardized,2021,507,Other cardiovascular and circulatory diseases,DALYs (Disability-Adjusted Life Years),Rate,0.0012597690,0.0014711220,0.001081843032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,492,Rheumatic heart disease,Prevalence,Rate,0.0087510830,0.0105506260,0.006861105032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,493,Ischemic heart disease,Prevalence,Rate,0.0431619540,0.0465242000,0.039063769032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,495,Ischemic stroke,Prevalence,Rate,0.0101837190,0.0106721790,0.009790472032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,496,Intracerebral hemorrhage,Prevalence,Rate,0.0017867610,0.0019103910,0.001675175032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,497,Subarachnoid hemorrhage,Prevalence,Rate,0.0008301510,0.0008900520,0.000772295032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,498,Hypertensive heart disease,Prevalence,Rate,0.0009846030,0.0013675280,0.000635584032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,968,Non-rheumatic calcific aortic valve disease,Prevalence,Rate,0.0014759990,0.0017397100,0.001234973032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,969,Non-rheumatic degenerative mitral valve disease,Prevalence,Rate,0.0048199570,0.0056781580,0.004173479032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,970,Other non-rheumatic valve diseases,Prevalence,Rate,0.0000027600,0.0000034100,0.000002200032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,942,Myocarditis,Prevalence,Rate,0.0000601000,0.0000688000,0.000052000032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,938,Alcoholic cardiomyopathy,Prevalence,Rate,0.0000569000,0.0000675000,0.000046700032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,944,Other cardiomyopathy,Prevalence,Rate,0.0006273080,0.0007437060,0.000511636032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,1004,Pulmonary Arterial Hypertension,Prevalence,Rate,0.0000234000,0.0000289000,0.000019200032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,500,Atrial fibrillation and flutter,Prevalence,Rate,0.0054565030,0.0068765260,0.004165730032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,501,Aortic aneurysm,Prevalence,Rate,NA,NA,NA32,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,502,Lower extremity peripheral arterial disease,Prevalence,Rate,0.0099512280,0.0113561610,0.008802271032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,503,Endocarditis,Prevalence,Rate,0.0000095400,0.0000110000,0.000008190032,Central Asia,32,Central Asia,3,Both,27,Age-standardized,2021,507,Other cardiovascular and circulatory diseases,Prevalence,Rate,0.0049942510,0.0061623980,0.003854522032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,492,Rheumatic heart disease,Deaths,Number,2831.5723010000,3248.8819280000,2465.831729000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,492,Rheumatic heart disease,Prevalence,Number,871505.3999000000,1049914.6600000000,681259.869800000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,493,Ischemic heart disease,Deaths,Number,175844.5664000000,192606.0866000000,161002.567600000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,493,Ischemic heart disease,Prevalence,Number,3110688.6360000000,3352363.6760000000,2760847.418000000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,495,Ischemic stroke,Deaths,Number,46716.5322700000,50990.3686000000,42822.917200000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,495,Ischemic stroke,Prevalence,Number,844342.6811000000,875732.8094000000,815481.871300000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,496,Intracerebral hemorrhage,Deaths,Number,36501.5463600000,40859.3544100000,33209.898890000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,496,Intracerebral hemorrhage,Prevalence,Number,168275.0706000000,179495.7690000000,158363.516000000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,497,Subarachnoid hemorrhage,Deaths,Number,4225.5009400000,4775.1890400000,3782.610628000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,497,Subarachnoid hemorrhage,Prevalence,Number,78238.6936800000,84081.7547600000,73085.366800000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,498,Hypertensive heart disease,Deaths,Number,14628.6136400000,16767.3722200000,12428.606560000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,498,Hypertensive heart disease,Prevalence,Number,64840.7713800000,87394.6863900000,45207.054630000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,968,Non-rheumatic calcific aortic valve disease,Deaths,Number,222.7343690000,249.0942105000,192.966192300032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,968,Non-rheumatic calcific aortic valve disease,Prevalence,Number,107363.5619000000,126641.2313000000,89674.748740000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,969,Non-rheumatic degenerative mitral valve disease,Deaths,Number,230.2305950000,257.3138114000,200.451129200032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,969,Non-rheumatic degenerative mitral valve disease,Prevalence,Number,322875.7132000000,380575.9446000000,274394.993900000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,970,Other non-rheumatic valve diseases,Deaths,Number,62.8729307200,77.6197568900,50.752589410032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,970,Other non-rheumatic valve diseases,Prevalence,Number,221.5044049000,277.9917471000,176.318958500032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,942,Myocarditis,Deaths,Number,774.9815378000,995.7351294000,595.158202000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,942,Myocarditis,Prevalence,Number,5427.7508790000,6313.0278470000,4670.052347000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,938,Alcoholic cardiomyopathy,Deaths,Number,1002.3448630000,1284.6523020000,749.227965600032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,938,Alcoholic cardiomyopathy,Prevalence,Number,5361.0457290000,6420.5396580000,4331.184517000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,944,Other cardiomyopathy,Deaths,Number,10679.0225800000,13072.0542500000,8496.038525000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,944,Other cardiomyopathy,Prevalence,Number,53935.2530900000,63291.4264100000,44163.729010000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,1004,Pulmonary Arterial Hypertension,Deaths,Number,333.7254145000,401.5616619000,266.195497700032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,1004,Pulmonary Arterial Hypertension,Prevalence,Number,2161.4499890000,2729.0693910000,1772.350839000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,500,Atrial fibrillation and flutter,Deaths,Number,1494.1854580000,1636.4700040000,1346.967308000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,500,Atrial fibrillation and flutter,Prevalence,Number,367235.6462000000,464899.0280000000,284294.330500000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,501,Aortic aneurysm,Deaths,Number,1510.0049520000,1689.9982190000,1295.763647000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,501,Aortic aneurysm,Prevalence,Number,NA,NA,NA32,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,502,Lower extremity peripheral arterial disease,Deaths,Number,324.0208989000,378.2147880000,281.850368800032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,502,Lower extremity peripheral arterial disease,Prevalence,Number,710899.7462000000,825166.0305000000,616934.388700000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,503,Endocarditis,Deaths,Number,156.9159308000,179.9202939000,136.768081600032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,503,Endocarditis,Prevalence,Number,861.0063491000,998.7451638000,728.862833500032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,507,Other cardiovascular and circulatory diseases,Deaths,Number,2170.0892640000,2431.9165020000,1918.591871000032,Central Asia,32,Central Asia,3,Both,22,All Ages,2021,507,Other cardiovascular and circulatory diseases,Prevalence,Number,404880.9638000000,505456.4113000000,314189.9356000000